| Jianlin Chen,Yunmian Chu,Jin He,Lei Zheng,Xu Che. Precision medicine in the treatment of pancreatic ductal adenocarcinoma. Oncol Transl Med, 2016, 2: 150-155. |
| Precision medicine in the treatment of pancreatic ductal adenocarcinoma |
| Received:May 05, 2016 Revised:August 04, 2016 |
| View Full Text View/Add Comment Download reader |
| KeyWord:pancreatic ductal adenocarcinoma (PDAC); precision medicine; chemotherapy; immunotherapy; cancer genomics |
| Author Name | Affiliation | E-mail | | Jianlin Chen | Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China | jchen216@jhmi.edu | | Yunmian Chu | Department of Abdominal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences and Perking Union Medical College, Beijing 100021, China | Yunmian.Chu@cicams.ac.cn | | Jin He | Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States | jhe11@jhmi.edu | | Lei Zheng | Department of Oncology, The Sidney Kimmel Cancer Center, Department of Surgery, The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States | lzheng6@jhmi.edu | | Xu Che | Department of Abdominal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences and Perking Union Medical College, Beijing 100021, China | xu.che@cicams.ac.cn |
|
| Hits: 6897 |
| Download times: 8465 |
| Abstract: |
| Pancreatic cancer has a poor prognosis. Current therapies for pancreatic cancer have limited effects. In the
past decade, precision medicine has shown great potential for clinical applications. In this review, different
strategies for applying precision medicine to the treatment of pancreatic cancer are described. |
| Close |
|
|
|